Molecular imaging of brain amyloid in mild cognitive impairment and Alzheimer's disease

被引：1
|
作者：
Matthews, P. M.
机构：
[1] Hammersmith Hosp, GSK Clin Imaging Ctr, London W12 0NN, England
[2] GlaxoSmithKline Inc, London, England
来源：
NATURE CLINICAL PRACTICE NEUROLOGY | 2007年 / 3卷 / 07期
关键词：
Alzheimer's disease; diagnosis; FDDNP-PET; FDG-PET; mild cognitive impairment;
D O I：
10.1038/ncpneuro0520
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：366 / 367
页数：2
相关论文
共 50 条
  • [1] Molecular imaging of brain amyloid in mild cognitive impairment and Alzheimer's disease
    Paul M Matthews
    [J]. Nature Clinical Practice Neurology, 2007, 3 : 366 - 367
  • [2] Brain imaging of mild cognitive impairment and Alzheimer's disease
    Yin, Changhao
    Li, Siou
    Zhao, Weina
    Feng, Jiachun
    [J]. NEURAL REGENERATION RESEARCH, 2013, 8 (05) : 435 - 444
  • [3] Brain imaging of mild cognitive impairment and Alzheimer's disease
    Changhao Yin
    Siou Li
    Weina Zhao
    Jiachun Feng
    [J]. Neural Regeneration Research, 2013, 8 (05) : 435 - 444
  • [4] Molecular imaging of neuroinflammation in Alzheimer's disease and mild cognitive impairment
    Knezevic, Dunja
    Mizrahi, Romina
    [J]. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2018, 80 : 123 - 131
  • [5] Applications of amyloid, tau, and neuroinflammation PET imaging to Alzheimer's disease and mild cognitive impairment
    Chandra, Avinash
    Valkimadi, Polytimi-Eleni
    Pagano, Gennaro
    Cousins, Oliver
    Dervenoulas, George
    Politis, Marios
    [J]. HUMAN BRAIN MAPPING, 2019, 40 (18) : 5424 - 5442
  • [6] Amyloid PET and MRI in Alzheimer's Disease and Mild Cognitive Impairment
    Dimou, E.
    Booij, J.
    Rodrigues, M.
    Prosch, H.
    Attems, J.
    Knoll, P.
    Zajicek, B.
    Dudczak, R.
    Mostbeck, G.
    Kuntner, C.
    Langer, O.
    Bruecke, T.
    Mirzaei, S.
    [J]. CURRENT ALZHEIMER RESEARCH, 2009, 6 (03) : 312 - 319
  • [7] Brain inflammation accompanies amyloid in the majority of mild cognitive impairment cases due to Alzheimer's disease
    Parbo, Peter
    Ismail, Rola
    Hansen, Kim V.
    Amidi, Ali
    Marup, Frederik H.
    Gottrup, Hanne
    Braendgaard, Hans
    Eriksson, Bengt O.
    Eskildsen, Simon F.
    Lund, Torben E.
    Tietze, Anna
    Edison, Paul
    Pavese, Nicola
    Stokholm, Morten G.
    Borghammer, Per
    Hinz, Rainer
    Aanerud, Joel
    Brooks, David J.
    [J]. BRAIN, 2017, 140 : 2002 - 2011
  • [8] Association of brain amyloid-β with cerebral perfusion and structure in Alzheimer's disease and mild cognitive impairment
    Mattsson, Niklas
    Tosun, Duygu
    Insel, Philip S.
    Simonson, Alix
    Jack, Clifford R., Jr.
    Beckett, Laurel A.
    Donohue, Michael
    Jagust, William
    Schuff, Norbert
    Weiner, Michael W.
    [J]. BRAIN, 2014, 137 : 1550 - 1561
  • [9] Plasma lipoprotein β-amyloid in subjects with Alzheimer's disease or mild cognitive impairment
    Mamo, J. C. L.
    Jian, L.
    James, A. P.
    Flicker, L.
    Esselmann, H.
    Wiltfang, J.
    [J]. ANNALS OF CLINICAL BIOCHEMISTRY, 2008, 45 : 395 - 403
  • [10] Trail Making Test B and brain perfusion imaging in mild cognitive impairment and mild Alzheimer's disease
    Terada, Seishi
    Sato, Shuhei
    Nagao, Shigeto
    Ikeda, Chikako
    Shindo, Aki
    Hayashi, Satoshi
    Oshima, Etsuko
    Yokota, Osamu
    Uchitomi, Yosuke
    [J]. PSYCHIATRY RESEARCH-NEUROIMAGING, 2013, 213 (03) : 249 - 255
12345